|
|||||
|
|
Pexelizumab,an anti-C5 complement antibody,as adjunctive therapy to primary percutaneous coronary intervention in acute myocardial infarction: the COMplement inhibition in Myocardial infarction treated with Angioplasty (COMMA) trial |
|
| Authors: | Granger Christopher B Mahaffey Kenneth W Weaver W Douglas Theroux Pierre Hochman Judith S Filloon Thomas G Rollins Scott Todaro Thomas G Nicolau Jose C Ruzyllo Witold Armstrong Paul W;COMMA Investigators |
| Institution: | Duke Clinical Research Institute, PO Box 17969, Durham, NC 27715, USA. grang001@mc.duke.edu |
| Abstract: | |
| Keywords: | |
| 本文献已被 PubMed 等数据库收录！ | |